ATE412418T1 - Zusammensetzungen zur erhöhung der zahl antigen präsentierender zellen und der antitumoralen antwort in menschlichen patienten - Google Patents
Zusammensetzungen zur erhöhung der zahl antigen präsentierender zellen und der antitumoralen antwort in menschlichen patientenInfo
- Publication number
- ATE412418T1 ATE412418T1 AT99916354T AT99916354T ATE412418T1 AT E412418 T1 ATE412418 T1 AT E412418T1 AT 99916354 T AT99916354 T AT 99916354T AT 99916354 T AT99916354 T AT 99916354T AT E412418 T1 ATE412418 T1 AT E412418T1
- Authority
- AT
- Austria
- Prior art keywords
- csf
- present
- antigen
- apc
- tumor
- Prior art date
Links
- 230000006023 anti-tumor response Effects 0.000 title 1
- 210000000612 antigen-presenting cell Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 abstract 5
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 abstract 5
- 108090000978 Interleukin-4 Proteins 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 239000002243 precursor Substances 0.000 abstract 3
- 238000007910 systemic administration Methods 0.000 abstract 2
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 abstract 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8051298P | 1998-04-02 | 1998-04-02 | |
| US11578899P | 1999-01-13 | 1999-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412418T1 true ATE412418T1 (de) | 2008-11-15 |
Family
ID=26763616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99916354T ATE412418T1 (de) | 1998-04-02 | 1999-04-02 | Zusammensetzungen zur erhöhung der zahl antigen präsentierender zellen und der antitumoralen antwort in menschlichen patienten |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1076564B1 (de) |
| JP (1) | JP2002510642A (de) |
| AT (1) | ATE412418T1 (de) |
| AU (1) | AU748850B2 (de) |
| CA (1) | CA2326739A1 (de) |
| DE (1) | DE69939821D1 (de) |
| WO (1) | WO1999051257A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1305041E (pt) * | 2000-07-28 | 2006-09-29 | Liponova Ag | Medicamento para a imunoterapia de tumores malignos |
| US20020094323A1 (en) | 2000-10-12 | 2002-07-18 | Kristoffer Hellstrand | Methods and compositions for promoting the maturation of monocytes |
| US7695723B2 (en) * | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| JP6430949B2 (ja) * | 2012-10-23 | 2018-11-28 | エモリー ユニバーシティ | Ｇｍ−ｃｓｆとｉｌ−４のコンジュゲート、組成物、ならびにそれに関連する方法 |
| WO2017175200A1 (en) | 2016-04-08 | 2017-10-12 | The Regents Of The University Of California | Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277368B1 (en) * | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
| AU4818297A (en) * | 1996-10-16 | 1998-05-11 | Johns Hopkins University, The | Cytokine enhanced immunotherapy for brain tumors |
-
1999
- 1999-04-02 AT AT99916354T patent/ATE412418T1/de not_active IP Right Cessation
- 1999-04-02 JP JP2000542028A patent/JP2002510642A/ja active Pending
- 1999-04-02 CA CA002326739A patent/CA2326739A1/en not_active Abandoned
- 1999-04-02 DE DE69939821T patent/DE69939821D1/de not_active Expired - Fee Related
- 1999-04-02 EP EP99916354A patent/EP1076564B1/de not_active Expired - Lifetime
- 1999-04-02 AU AU34695/99A patent/AU748850B2/en not_active Ceased
- 1999-04-02 WO PCT/US1999/007376 patent/WO1999051257A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69939821D1 (de) | 2008-12-11 |
| JP2002510642A (ja) | 2002-04-09 |
| AU748850B2 (en) | 2002-06-13 |
| CA2326739A1 (en) | 1999-10-14 |
| EP1076564B1 (de) | 2008-10-29 |
| AU3469599A (en) | 1999-10-25 |
| WO1999051257A1 (en) | 1999-10-14 |
| EP1076564A1 (de) | 2001-02-21 |
| EP1076564A4 (de) | 2005-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2298418T3 (es) | Procedimiento para la preparacion de una libreria de arnm de antigenos tumorales. | |
| CA2727388C (en) | Telomerase-derived peptides for use in treatment of cancer | |
| JP2020023525A (ja) | ペプチド混合物 | |
| Lichtor et al. | Prolonged survival of mice with glioma injected intracerebrally with double cytokine—secreting cells | |
| WO2005079867A3 (en) | Alpha-emitting hydroxyapatite particles | |
| HUP0101619A2 (hu) | Adjuvánskészítmények | |
| HUP0303125A2 (hu) | Bcl-2 rendellenességek kezelésére szolgáló eljárások bcl-2 antiszenz oligomerekkel | |
| HUP0103598A2 (hu) | Készítmények és eljárások WT1-specifikus immunterápiás alkalmazásra | |
| IL169002A (en) | A preparation containing partially dendritic cells in vitro | |
| BR0207819A (pt) | Proteìna, citocina, il-13 humano mutado, polinucleotìdeo, vetor, hospedeiro, composição farmacêutica, uso de uma proteìna, métodos para o tratamento de profilaxia de doença mediada por il-13, e para a preparação de uma proteìna | |
| Tamir et al. | Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors | |
| Gregoire et al. | Anti-cancer therapy using dendritic cells and apoptotic tumour cells: pre-clinical data in human mesothelioma and acute myeloid leukaemia | |
| IL153288A0 (en) | Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis | |
| Dalgleish | Cancer vaccines | |
| ATE412418T1 (de) | Zusammensetzungen zur erhöhung der zahl antigen präsentierender zellen und der antitumoralen antwort in menschlichen patienten | |
| HUP0204216A2 (en) | A new use of antibodies as vaccines | |
| WO2004104591A3 (en) | Improvements to gamma delta t cell-mediated therapy | |
| JP2004531496A (ja) | 樹状細胞の成熟を誘導するグラム陰性細菌膜画分の使用方法 | |
| BR9915071A (pt) | Utilização de uma proteìna ompa de enterobactéria ou de um de seus fragmentos | |
| WO2001029192A3 (en) | Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses | |
| Suntharalingam et al. | The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. | |
| Loducca et al. | Intraosseous rhabdomyosarcoma of the mandible: a case report | |
| MY141122A (en) | Vaccine composition containing transforming growth factor alpha (tgf[alpha]). it use in malignant diseases therapy | |
| ATE544492T1 (de) | Alpha- und beta-emittierende hydroxyapatit- teilchen | |
| Slovin et al. | Emerging role of immunotherapy in the management of prostate cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |